Federal grants to Virogenomics Biodevelopment, Inc.
Virogenomics Biodevelopment, Inc. in Portland, Oregon received $5.7 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Drug Use and Addiction Research Programs, with $3.7 million. In fiscal 2025 it was awarded $3.3 million.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$5.7 million
- Awards4
- Awarded in FY 2025$3.3 million
- Largest award$3.3 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $996,926 |
| FY 2022 | 2 | $996,486 |
| FY 2023 | 0 | $0 |
| FY 2024 | 1 | $405,334 |
| FY 2025 | 1 | $3.3 million |
Programs that fund Virogenomics Biodevelopment, Inc.
| Program | Awards | Amount |
|---|---|---|
| Drug Use and Addiction Research Programs | 2 | $3.7 million |
| Allergy and Infectious Diseases Research | 1 | $2.0 million |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 1 | $0 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $5.7 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Ind-enabling studies and phase i clinical trials to advance CD74-TARGET, drhq, as a treatment for stimulant use disorder - project abstract methamphetamine (MA) is a highly addictive central nervous system (CNS) psychostimulant. Ma causes long- term damage to regions of the brain that regulate cogni | Drug Use and Addiction Research Programs | May 12, 2025 | $3.3 million |
| Development of dr?1-MOG-35-55 for treatment of DR2 negative ms subjects | Allergy and Infectious Diseases Research | March 17, 2021 | $2.0 million |
| Immunotherapeutic targeting CD74 as a treatment for stimulant use disorder - project abstract methamphetamine is a highly addictive central nervous system (CNS) psychostimulant that causes long-term damage to regions of the brain that regulate cognitive and psychiatric functions and promote drug-see | Drug Use and Addiction Research Programs | June 6, 2024 | $405,334 |
| Dr?1-MOG: a novel immunomodulatory therapeutic for stroke | Extramural Research Programs in the Neurosciences and Neurological Disorders | September 26, 2022 | $0 |
Questions people ask
How much federal grant money does Virogenomics Biodevelopment, Inc. get?
$5.7 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Virogenomics Biodevelopment, Inc. the most?
The Department of Health and Human Services, with $5.7 million in 4 awards.
What is Virogenomics Biodevelopment, Inc.'s largest federal grant?
$3.3 million under Drug Use and Addiction Research Programs, with its first action in the period on May 12, 2025. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Virogenomics Biodevelopment, Inc.?
Its largest are Drug Use and Addiction Research Programs, Allergy and Infectious Diseases Research and Extramural Research Programs in the Neurosciences and Neurological Disorders.
Other grant recipients in Portland
- Oregon Health & Science University
- Tri-County Metropolitan Transportation District of Oregon
- Oregon Department of Housing & Community Services
- Mercy Corps
- Pacific States Marine Fisheries Commission
- Oregon Department of Environmental Quality
- Port of Portland
- Portland State University
Largest federal grant recipients in Oregon · Federal grants in Oregon